Insider Trading History of Xanthopoulos Kleanthis G

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Xanthopoulos Kleanthis G since 2005. The trader's CIK number is 1283304. At the time of the last reporting, Xanthopoulos Kleanthis G was the Director of Zosano Pharma Corp. (stock ticker symbol ZSAN). Also see all insider trading activities at Zosano Pharma Corp.

Note that in the past XANTHOPOULOS KLEANTHIS G also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Anadys Pharmaceuticals Inc (ANDS) by Xanthopoulos Kleanthis G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 ANDS 6,500 $13,955 0 $0 0 $0
2006 ANDS 0 $0 91,241 $1,277,996 60,000 $177,000
2005 ANDS 0 $0 35,000 $378,555 0 $0

Yearly summary of insider trading at Regulus Therapeutics Inc. (RGLS) by Xanthopoulos Kleanthis G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 RGLS 0 $0 440,000 $8,009,137 440,000 $167,198
2014 RGLS 0 $0 38,555 $342,062 38,555 $14,641

Yearly summary of insider trading at Zosano Pharma Corp (ZSAN) by Xanthopoulos Kleanthis G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ZSAN 15,920 $21,014 0 $0 0 $0

Yearly summary of insider trading at Apricus Biosciences, Inc. (APRI) by Xanthopoulos Kleanthis G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 APRI 0 $0 28,640 $75,330 0 $0
2012 APRI 0 $0 15,625 $47,846 0 $0


Insider trading activities at 4 companies by Xanthopoulos Kleanthis G:

1. Anadys Pharmaceuticals Inc (ANDS)

2. Regulus Therapeutics Inc. (RGLS)

3. Zosano Pharma Corp (ZSAN)

4. Apricus Biosciences, Inc. (APRI)

Table 1. Insider trading of Anadys Pharmaceuticals Inc (ANDS) by Xanthopoulos Kleanthis G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-08-16 ANDS Buy 6,500 2.15 13,955
2006-11-14 ANDS Sale 100 5.00 500
2006-05-15 ANDS Sale 5,000 10.49 52,440
2006-04-17 ANDS Sale 5,000 14.82 74,125
2006-03-20 ANDS Sale 5,000 15.36 76,800
2006-03-07 ANDS Option Ex 30,000 2.95 88,500
2006-03-07 ANDS Sale 30,000 14.67 440,100
2006-03-07 ANDS Option Ex 30,000 2.95 88,500
2006-03-07 ANDS Sale 30,000 14.67 440,100
2006-02-28 ANDS Sale 6,141 12.99 79,747
2006-02-21 ANDS Sale 5,000 11.81 59,050
2006-01-17 ANDS Sale 5,000 11.03 55,134
2005-12-19 ANDS Sale 5,000 8.15 40,740
2005-11-21 ANDS Sale 5,000 10.58 52,920
2005-10-17 ANDS Sale 5,000 10.90 54,490
2005-09-19 ANDS Sale 5,000 13.38 66,895
2005-08-15 ANDS Sale 5,000 12.84 64,185
2005-07-18 ANDS Sale 5,000 11.24 56,220
2005-06-21 ANDS Sale 5,000 8.62 43,105

Table 2. Insider trading of Regulus Therapeutics Inc. (RGLS) by Xanthopoulos Kleanthis G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-04-20 RGLS Sale 66,071 16.85 1,113,494
2015-04-21 RGLS Sale 60,000 17.73 1,063,980
2015-04-17 RGLS Option Ex 73,929 .38 28,093
2015-04-17 RGLS Sale 73,929 16.93 1,251,987
2015-04-20 RGLS Option Ex 66,071 .38 25,106
2015-04-21 RGLS Option Ex 60,000 .38 22,800
2015-03-05 RGLS Sale 89,230 20.44 1,823,771
2015-03-05 RGLS Option Ex 89,230 .38 33,907
2015-02-27 RGLS Sale 70 19.50 1,365
2015-02-27 RGLS Option Ex 70 .38 26
2015-01-30 RGLS Sale 3,300 19.50 64,350
2015-02-02 RGLS Sale 2,400 19.77 47,440
2015-01-30 RGLS Option Ex 3,300 .38 1,254
2015-02-02 RGLS Option Ex 2,400 .38 912
2015-01-29 RGLS Option Ex 60,000 .38 22,800
2015-01-28 RGLS Option Ex 85,000 .38 32,300
2015-01-29 RGLS Sale 60,000 18.08 1,085,040
2015-01-28 RGLS Sale 85,000 18.33 1,557,710
2014-10-29 RGLS Sale 3,505 19.62 68,757
2014-10-29 RGLS Option Ex 3,505 .38 1,331
2014-10-17 RGLS Option Ex 400 .38 152
2014-10-17 RGLS Sale 400 7.04 2,816
2014-10-20 RGLS Option Ex 300 .38 114
2014-10-20 RGLS Sale 300 7.00 2,100
2014-10-14 RGLS Option Ex 400 .38 152
2014-10-09 RGLS Sale 105 7.00 735
2014-10-09 RGLS Option Ex 105 .38 39
2014-10-14 RGLS Sale 400 7.00 2,800
2014-09-30 RGLS Sale 2,300 7.02 16,136
2014-09-30 RGLS Option Ex 2,300 .38 874
2014-08-28 "RGLS" Sale 3,505 7.06 24,755
2014-08-28 "RGLS" Option Ex 3,505 .38 1,331
2014-08-05 "RGLS" Sale 3,505 7.06 24,738
2014-08-05 "RGLS" Option Ex 3,505 .38 1,331
2014-07-01 "RGLS" Option Ex 3,505 .38 1,331
2014-07-01 "RGLS" Sale 3,505 8.11 28,425
2014-06-09 "RGLS" Option Ex 3,505 .38 1,331
2014-06-09 "RGLS" Sale 3,505 7.14 25,018
2014-05-28 "RGLS" Option Ex 875 .38 332
2014-05-27 "RGLS" Sale 1,743 7.00 12,202
2014-05-29 "RGLS" Option Ex 887 .38 337
2014-05-28 "RGLS" Sale 875 7.00 6,125
2014-05-29 "RGLS" Sale 887 7.00 6,209
2014-05-27 "RGLS" Option Ex 1,743 .38 662
2014-03-06 "RGLS" Sale 3,505 7.60 26,623
2014-03-06 "RGLS" Option Ex 3,505 .38 1,331
2014-03-06 "RGLS" Option Ex 3,505 .38 1,331
2014-03-06 "RGLS" Sale 3,505 11.35 39,778
2014-02-05 "RGLS" Sale 3,505 8.40 29,438
2014-02-05 "RGLS" Option Ex 3,505 .38 1,331
2014-01-02 RGLS Option Ex 3,505 .38 1,331
2014-01-02 RGLS Sale 3,505 7.25 25,407

Table 3. Insider trading of Zosano Pharma Corp (ZSAN) by Xanthopoulos Kleanthis G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-08-19 ZSAN Buy 15,920 1.32 21,014

Table 4. Insider trading of Apricus Biosciences, Inc. (APRI) by Xanthopoulos Kleanthis G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-26 APRI Sale 17,184 2.55 43,819
2013-06-21 APRI Sale 2,864 2.52 7,217
2013-05-21 APRI Sale 2,864 3.36 9,611
2013-04-22 APRI Sale 2,864 2.63 7,523
2013-03-21 APRI Sale 2,864 2.50 7,160
2012-09-28 APRI Sale 3,125 3.25 10,159
2012-08-15 APRI Sale 12,500 3.02 37,687

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Xanthopoulos Kleanthis G (Director of Zosano Pharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.